Accuray Inc
ARAY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001138723
No open-market purchases or sales by Accuray Inc insiders were filed in the last 90 days; 91 institutions reported holding it in 13F filings for Q3 2026, worth $29.1M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:41 PM ET
Revenue flow, FY2026
Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2026: $49.2M (12.2% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Aug 19, 2026 | Aug 13, 2025 | Aug 14, 2024 | Aug 9, 2023 | Aug 10, 2022 |
| Revenue | $401.9M | $458.5M | $446.6M | $447.6M | $429.9M |
| Cost of revenue | $290.5M | $311.5M | $303.6M | $293.6M | $270.0M |
| Gross profit | $111.5M | $147.0M | $142.9M | $154.0M | $160.0M |
| Operating expenses | $137.9M | $139.1M | $142.4M | $151.6M | $151.8M |
| Research and development | $37.8M | $47.9M | $49.7M | $57.1M | $57.8M |
| Selling, general and administrative | $45.4M | $47.9M | $50.1M | $48.3M | $44.4M |
| Operating income | -$26.4M | $7.84M | $504.0K | $2.38M | $8.15M |
| Interest expense | $32.1M | $13.0M | $11.6M | $10.6M | $8.13M |
| Income tax | $1.95M | $2.73M | $3.73M | $2.49M | $3.35M |
| Net income | -$49.2M | -$1.59M | -$15.5M | -$9.28M | -$5.35M |
| EPS, basic | $-0.40 | $-0.02 | $-0.16 | $-0.10 | $-0.06 |
| EPS, diluted | – | $-0.02 | $-0.16 | $-0.10 | $-0.06 |
| Weighted shares, basic | 122.6M | 102.8M | 98.3M | 94.9M | 92.1M |
| Weighted shares, diluted | – | 102.8M | 98.3M | 94.9M | 92.1M |
| Margins and growth | |||||
| Gross margin | 27.7% | 32.1% | 32.0% | 34.4% | 37.2% |
| Operating margin | -6.6% | 1.7% | 0.1% | 0.5% | 1.9% |
| Net margin | -12.2% | -0.3% | -3.5% | -2.1% | -1.2% |
| Revenue growth, year over year | −12.3% | +2.7% | −0.2% | +4.1% | +8.5% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Aug 19, 2026 | Aug 13, 2025 | Aug 14, 2024 | Aug 9, 2023 | Aug 10, 2022 |
| Cash and equivalents | $40.6M | $57.4M | $68.6M | $89.4M | $88.7M |
| Accounts receivable | $67.4M | $83.2M | $92.0M | $74.8M | $94.4M |
| Inventory | $147.1M | $141.0M | $138.3M | $145.2M | $142.3M |
| Total current assets | $287.8M | $317.5M | $323.2M | $338.0M | $350.9M |
| Property, plant and equipment | $27.3M | $28.7M | $24.8M | $20.9M | $12.7M |
| Goodwill | $57.9M | $57.8M | $57.7M | $57.7M | $57.8M |
| Intangible assets | $0 | $15.0K | $59.0K | $210.0K | $250.0K |
| Total assets | $443.7M | $470.2M | $468.6M | $479.2M | $472.8M |
| Accounts payable | $40.6M | $34.0M | $50.0M | $33.7M | $31.3M |
| Short-term debt | $1.50M | $12.7M | $7.76M | $5.72M | $8.56M |
| Total current liabilities | $191.4M | $192.6M | $195.3M | $198.6M | $208.9M |
| Long-term debt | $146.4M | $123.8M | $164.4M | $171.6M | $171.9M |
| Total liabilities | $402.0M | $389.1M | $423.5M | $425.6M | $419.7M |
| Shareholders' equity | $41.7M | $81.2M | $45.1M | $53.7M | $53.2M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Aug 19, 2026 | Aug 13, 2025 | Aug 14, 2024 | Aug 9, 2023 | Aug 10, 2022 |
| Operating cash flow | -$6.98M | $2.86M | -$11.9M | $15.5M | -$2.40M |
| Capital expenditures | $5.86M | $4.27M | $3.60M | $12.6M | $4.72M |
| Free cash flow | -$12.8M | -$1.41M | -$15.5M | $2.92M | -$7.12M |
| Depreciation and amortization | $7.94M | $6.15M | $5.91M | $4.53M | $5.51M |
| Stock-based compensation | $6.46M | $10.2M | $9.48M | $10.1M | $10.6M |
| Share buybacks | – | – | – | $0 | $0 |
| Investing cash flow | -$12.3M | -$8.52M | -$3.60M | -$12.7M | -$4.72M |
| Financing cash flow | $6.98M | -$4.25M | -$3.95M | -$2.11M | -$15.4M |
| Net change in cash | -$13.4M | -$8.26M | -$20.8M | $1.05M | -$28.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.6% | 2.2% | 2.1% | 2.2% | 2.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 31, 2026 | 120.2M | +6.0% | SEC |
| Aug 21, 2026 | 119.4M | +6.0% | SEC |
| Apr 30, 2026 | 119.0M | +15.5% | SEC |
| Jan 30, 2026 | 118.8M | +15.5% | SEC |
| Oct 31, 2025 | 113.3M | +12.7% | SEC |
| Aug 22, 2025 | 112.7M | +12.4% | SEC |
| Apr 30, 2025 | 103.0M | +3.8% | SEC |
| Jan 31, 2025 | 102.8M | +3.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.